Brain Blogger Home
  • Home
  • About
    • Editor's Note
    • Contributors
  • Advertise
  • Archives
    • By Author
    • By Topic
    • By Year
    • By Month
  • Contact
  • Contribute
  • Topics
    • Popular
    • Series
    • Video
    • Carnivals
  • Sitemap
  • Subscribe
  • Neuroscience & Neurology
  • Psychology & Psychiatry
  • Health & Healthcare
  • More >>
    • BioPsychoSocial Health
    • Complementary & Alternative Medicine
    • Drugs & Clinical Trials
    • History of Medicine
    • Law & Politics
    • Living with a Brain Disorder
    • Opinion
    • Site News
    • Stigmatization
Brain Blogger RSS Feed

Brain Blogger Feed - 3500+ Readers

Follow BB:

Brain Blogger on FaceBook Brain Blogger on twitter Brain Blogger on Flickr Brain Blogger on YouTube
Psychology & Psychiatry
February 28, 2010

Psychotropics and Youth, Part 2 – The Solutions

By Courtney Sherman, BA | 8 Comments | Share | Print | Email | Tweet | Like | 1+
Child Front

“Prescribed psychotropic medications are now high on the research agenda,” assert Lakhan and Hagger-Johnson. Their study advocates new approaches to research to address the rising concern over dramatic increases in psychotropic prescriptions for both children and young.

Our first post delineated the five erroneous myths often adhered to when prescribing youth’s psychotropic medication. Here are the three areas of recommended research to address this “alarming” problem.

1) Clarify child/adult differences for psychotropics. The future promises to see questionnaires and interviews tailored specifically to children and adolescents. Prominent will be the initiation of normative data for youth mental disorders. Studies will need to focus on specific age groups, disorders and treatments.

2) Attend to the growth of “cosmetic” use of psychotropics in children and adolescents. Researchers’ alarm over the marked increase in psychotropic prescriptions for youth has spilled over into the public arena. Recent media attention, in conjunction with changes in clinical practice standards and drug product labeling, has juggernauted psychotropic investigation to the forefront of the research agenda.

3) Address concerns about the diagnostic validity of mental illness in the current DSM classification system. Due to lack of psychotropic research on youth, the current DSM system is flawed, Lakhan and Hagger-Johnson noted. Ethical challenges such as reluctance to enroll children in psychotropic clinical trials and the lack of “well-designed”, placebo-controlled trials have traditionally been barriers to effective research. Increasingly, the idea of hands-on research with children is more palatable.

Lakhan and Haggar-Johnson remind us that “for the first time, we can begin to record and measure, rather than assume, the impact of prescribed psychotropics on children and adolescents.” The final verdict — children and adolescents need accurate, age-appropriate data that does not exist today.

Reference

Lakhan, S., & Hagger-Johnson, G. (2007). The impact of prescribed psychotropics on youth Clinical Practice and Epidemiology in Mental Health, 3 (1) DOI: 10.1186/1745-0179-3-21

Courtney Sherman, BA

Ms. Sherman is a graduate of the University of California, Los Angeles (History). She is a writer living in Los Angeles.

Related Articles

  • Psychotropics and Youth, Part 1 – The Five Myths
  • Psychotropics and Youth, Part 3 – Equip Teachers with Prescription Pads?
  • Prevention of Adolescent Depression
  • Antidepressants – Who’s Prescribing What
  • Give a Clinical Trial a Try: It’ll Probably Cost Nothing
  • Common Treatment Ineffective for Autism
  • Antidepressants Carry Equal Risks

8 Responses

  1. Bill says:
    March 4, 2010 at 5:13 am

    Interesting piece. The third point really struck me. So the medical establishment believes its unethical to test these drugs on children — yet it’s all right to prescribe them willy-nilly without testing? Hello, people! — don’t we see a problem here?

    Reply
    • Shaheen E Lakhan, MS, MEd, PhD, MD says:
      March 5, 2010 at 7:54 am

      Dear Bill,

      I wrote on this issue for The Lancet Student last year:

      It is true that research done on children is ethically questionable but the medical community and critics should be aware that innovative non-invasive measures are being used worldwide to help make medications safer for children. The great myths in pediatrics — children are little adults and children can be prescribed a lower dose of the same drug — have been widely dispelled [Ref]. But, we must now measure pharmacokinetic, pharmacodynamic, and response effects across different age ranges and establish the true differences of drug effects on adult and pediatric populations. Perhaps virtual models can place us one step closer to this goal.

      You can read the full article here. I would like to know the public’s opinion on traditional clinical trials or using virtual models for testing medications on pediatric patients. Thank you.

      Sincerely,
      Shaheen

      Reply
  2. David Stein says:
    March 4, 2010 at 11:40 pm

    I agree Bill. They’d like to test children if society allowed it, but it’s not “in vogue” in the public sphere right now. You make a good point.

    Reply
  3. Courtney Sherman says:
    March 5, 2010 at 9:27 pm

    Thank you for your comments, Shaheen. Your article was quite interesting and your point astute. We should be well past the point where people recognize that children are not little adults, and be on a path to matching treatment to the specific ages and characteristics of the children involved. One-size-fits-all should never be a recipe for medical treatment of our children.

    Reply
  4. Richard Kensinger, MSW says:
    December 9, 2011 at 2:44 pm

    Psychotropics are clerly overprescribed for persons under the age of 10, even 5. Foster kids w/ “behavioral dyscontrol”, are 5 X more likely to be placed on “drug cocktails”, often 5 at a time!

    I have very serious concerns about the schedule 2 controlled agents: the psychostimulants. The US prescribes 85% of the world market!

    Likewise, the neuroleptics are very often inappropriately used in young kids. For example, for “irritability” in those w/ autism. They are only clinically indicated for those who are psychotic. In the clinical literature on autism, I see no concordance between autism & psychosis!

    The neuroleptics at high doses & for long durations, show a range of serious side-effects, & adverse events, such as TD & NMS. Some of these conditions are irreversable & lethal.

    Rich

    Reply
  1. Psychotropics and Youth, Part 1 – The Five Myths | Brain Blogger says:
    February 28, 2010 at 8:44 am

    [...] this grave problem. However, debate is continuing to grow about the over-reliance of psychotropics. In my next post, I will identify three areas of research that can provide answers to this alarming [...]

    Reply
  2. FakePlasticTree » ???????? part.2??????? says:
    March 9, 2010 at 9:04 pm

    [...] 2010 ? 3 ? 10 ? ???? ???????? ???? Psychotropics and Youth, Part 2 – The Solutions | Brain Blogger “Prescribed psychotropic medications are now high on the research agenda,” assert [...]

    Reply
  3. Psychotropics and Youth, Part 3 – Equip Teachers with Prescription Pads? | Brain Blogger says:
    April 8, 2010 at 9:23 am

    [...] teachers involved in the study’s answer to this dilemma? They want more training in the area of child psychopharmacology and more collaboration with parents and physicians who prescribe the medication, which at present [...]

    Reply

Leave a Reply

Click here to cancel reply.

Subscribe without commenting


Popular Posts

  • The Love Drug
  • Women After Sex
  • Fatty Acids and Suicide Risk
  • Mind Games - Science's Attempts at Thought Control
  • Risks of Personalized Medicine
  • Mental Health Disorders Prevalent Among Youth Worldwide
  • Is Giftedness Nothing More than Good Genes?
  • Behind the Masks - The Mysteries of Dissociative Identity Disorder
  • The NeuroSocial Network
  • Inside Your Brain on Holiday

Future Posts

  • The Brain’s Buying Power
  • Aging Intelligently

Latest Posts

  • A Nicotine Patch a Day Keeps the Cognitive Impairment Away
  • The Many Emerging Roles of Astrocytes
  • Diabetes Impairs Cognition
  • Media Violence Leads to Real Violence
  • Intelligence – Are You Holding Back Your Brain?
  • Childhood Aggression Predicts Health Care Use Later in Life
  • The Brain’s Border Patrol – Blood Brain Barrier
  • Risks of Personalized Medicine
  • BED-head and Obesity – Food for Thought
  • Salvia Divinorum – DEA Control over Magic in the Mint

Comments

  • Emily Haines, MSc, PhD student: Thanks for your comments, Matt
  • Emily Haines, MSc, PhD student: Thanks for your comments and s
  • Alex: While we have our eyes glued t
  • Richard Kensinger, MSW: Carla,You are absolutely c
  • Soraya L. Valles: I'm interested in astrocytes.
  • Raymond Tallis: Dear Kitty, I have come to you
  • Steven: After smoking for 17 years dai
  • Matt: I'm just interested in hearing
  • Carla Easley: If everyone adopted the "Growt
  • Isabel (retired RN): I second that query for resear
  • David: How about some citations to pe
  • MrsK: @Dawn - I agree with your stat
Sponsored Links

chinese wholesale, memory improvement, web design brisbane, Autism News Blog, Pharmaceutical Training, Neurotherapist, HGH, Rollup Banner Stands , Buy Seroquel , AtomicPR , substance abuse , Lab Tests Locations

Copyright © 2005-2012 Brain Blogger sponsored by Global Neuroscience Initiative Foundation (GNIF). All Rights Reserved.
Disclaimer | Privacy Policy | Feed | Log in | ISSN 1931-6224 | 1.056s
9rules Network Member